Mustang Bio Stock Analysis

MBIO Stock  USD 0.51  0.04  7.27%   
Mustang Bio is undervalued with Real Value of 4.72 and Target Price of 17.25. The main objective of Mustang Bio stock analysis is to determine its intrinsic value, which is an estimate of what Mustang Bio is worth, separate from its market price. There are two main types of Mustang Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Mustang Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Mustang Bio's stock to identify patterns and trends that may indicate its future price movements.
The Mustang Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Mustang Bio is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Mustang Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Mustang Bio's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Mustang Stock Analysis Notes

About 23.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 5.81. Mustang Bio had not issued any dividends in recent years. The entity had 1:15 split on the 4th of April 2023. Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people. To find out more about Mustang Bio contact Manuel MD at 781 652 4500 or learn more at https://www.mustangbio.com.

Mustang Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Mustang Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Mustang Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Mustang Bio generated a negative expected return over the last 90 days
Mustang Bio has high historical volatility and very poor performance
Mustang Bio has some characteristics of a very speculative penny stock
Mustang Bio has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (51.6 M) with profit before overhead, payroll, taxes, and interest of 0.
Mustang Bio currently holds about 107.37 M in cash with (49.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mustang Bio has a frail financial position based on the latest SEC disclosures
Roughly 23.0% of the company outstanding shares are owned by corporate insiders
Latest headline from finance.yahoo.com: Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Mustang Bio Upcoming and Recent Events

Earnings reports are used by Mustang Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mustang Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
3rd of April 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Mustang Largest EPS Surprises

Earnings surprises can significantly impact Mustang Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-14
2022-09-30-0.2-0.180.0210 
2022-05-12
2022-03-31-0.18-0.2-0.0211 
2022-03-23
2021-12-31-0.19-0.22-0.0315 
View All Earnings Estimates

Mustang Bio Thematic Classifications

In addition to having Mustang Bio stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
IT Idea
IT
Information technology and IT services

Mustang Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Mustang Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mustang Bio backward and forwards among themselves. Mustang Bio's institutional investor refers to the entity that pools money to purchase Mustang Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Macquarie Group Ltd2023-12-31
K
Fmr Inc2023-12-31
7.2 K
Tower Research Capital Llc2023-12-31
6.4 K
U.s. Bancorp2023-12-31
1000
Ubs Group Ag2023-12-31
1000
Nbc Securities Inc2023-09-30
400
Advisor Group Holdings, Inc.2023-12-31
361
Bank Of America Corp2023-12-31
211
Wells Fargo & Co2023-12-31
150
Armistice Capital, Llc2023-12-31
435.8 K
Vanguard Group Inc2023-12-31
179.6 K
Note, although Mustang Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mustang Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mustang Bio's market, we take the total number of its shares issued and multiply it by Mustang Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Mustang Profitablity

Mustang Bio's profitability indicators refer to fundamental financial ratios that showcase Mustang Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Mustang Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Mustang Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Mustang Bio's profitability requires more research than a typical breakdown of Mustang Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.91)(2.76)
Return On Capital Employed(21.39)(20.32)
Return On Assets(2.91)(2.76)
Return On Equity(419.53)(398.55)

Management Efficiency

Mustang Bio has return on total asset (ROA) of (0.5756) % which means that it has lost $0.5756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.2244) %, meaning that it created substantial loss on money invested by shareholders. Mustang Bio's management efficiency ratios could be used to measure how well Mustang Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 13th of April 2024, Return On Tangible Assets is likely to grow to -2.76. In addition to that, Return On Capital Employed is likely to grow to -20.32. At this time, Mustang Bio's Net Tangible Assets are very stable compared to the past year. As of the 13th of April 2024, Non Current Assets Total is likely to grow to about 8.8 M, while Total Assets are likely to drop about 16.9 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.01  0.01 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 0.01  0.01 
Enterprise Value Over EBITDA(0.16)(0.17)
Price Book Value Ratio 94.44  99.16 
Enterprise Value Multiple(0.16)(0.17)
Price Fair Value 94.44  99.16 
Enterprise Value7.9 M7.5 M
The analysis of Mustang Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Mustang Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Mustang Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.542

Technical Drivers

As of the 13th of April 2024, Mustang Bio secures the Standard Deviation of 5.63, mean deviation of 3.87, and Risk Adjusted Performance of (0.12). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mustang Bio, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Mustang Bio, which can be compared to its peers in the industry. Please verify Mustang Bio risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Mustang Bio is priced some-what accurately, providing market reflects its recent price of 0.51 per share. As Mustang Bio is a penny stock we also strongly advise to check its jensen alpha numbers.

Mustang Bio Price Movement Analysis

The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mustang Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mustang Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Mustang Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mustang Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mustang Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mustang Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Mustang Bio Predictive Daily Indicators

Mustang Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mustang Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Mustang Bio Forecast Models

Mustang Bio's time-series forecasting models are one of many Mustang Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mustang Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Mustang Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mustang Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mustang shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mustang Bio. By using and applying Mustang Stock analysis, traders can create a robust methodology for identifying Mustang entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.00  0.00 
Operating Profit Margin 0.00  0.00 
Net Profit Margin 0.00  0.00 
Gross Profit Margin 0.00  0.00 

Current Mustang Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mustang analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mustang analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.25Strong Buy3Odds
Mustang Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mustang analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mustang stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mustang Bio, talking to its executives and customers, or listening to Mustang conference calls.
Mustang Analyst Advice Details

Mustang Stock Analysis Indicators

Mustang Bio stock analysis indicators help investors evaluate how Mustang Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mustang Bio shares will generate the highest return on investment. By understating and applying Mustang Bio stock analysis, traders can identify Mustang Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow75.7 M
Common Stock Shares Outstanding8.6 M
Total Stockholder Equity123 K
Property Plant And Equipment Net4.8 M
Cash And Short Term Investments6.2 M
Cash6.2 M
Accounts Payable6.3 M
Net Debt-3.7 M
50 Day M A1.1401
Total Current Liabilities15.4 M
Other Operating Expenses50.7 M
Non Current Assets Total6.4 M
Non Currrent Assets Other833 K
Stock Based Compensation568 K
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Mustang Stock analysis

When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.81)
Revenue Per Share
(0)
Return On Assets
(0.58)
Return On Equity
(2.22)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.